Clinical trial

Analgesic Efficacy of Serratus Intercostal Block Versus Epidural Analgesia in Eventration Surgery : Prospective Observational Study

Name
22-EO132
Description
Adequate pain control, rehabilitation and early postoperative recovery are currently the model to follow according to the recommended guidelines.In this project the main objective is to evaluate 2 different analgesic strategies both intraoperatively and postoperatively, one based on 1. Epidural analgesia and the other 2. Echoguided serratus intercostal block prior to surgical intervention in eventration or abdominal wall repair interventions. We conducted an observational study with a low level of intervention. Epidural analgesia prior to general anesthesia and serratus-intercostal block prior to general anesthesia) following the criteria applied in each case according to the operating room anesthesiologist until reaching the sample size and fulfilling the criteria of: abdominal eventration repair, over 18 years of age, ASA I-III. Signature of the IC.
Trial arms
Trial start
2022-09-01
Estimated PCD
2023-08-01
Trial end
2024-12-31
Status
Recruiting
Treatment
undergo
regional anesthesia
Arms:
Patient under serratus intercostal plane block, patient under epidural analgesia
Other names:
Eventroplasty
ultrasound
ultrasound guided
Arms:
Patient under serratus intercostal plane block, patient under epidural analgesia
Other names:
Regional anesthesia
Local anesthetic
local anesthetic
Arms:
Patient under serratus intercostal plane block, patient under epidural analgesia
Other names:
Regional anesthesia
Size
80
Primary endpoint
postoperative pain management
24h
postoperative quality of recovery
24h
Eligibility criteria
Inclusion Criteria: * abdominal eventration repair, * over 18 years old, * ASA I-III. * Signature of the IC. Exclusion Criteria: * Allergy to Local anesthetic
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': True, 'targetDuration': '2 Years', 'designInfo': {'observationalModel': 'CASE_CONTROL', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 80, 'type': 'ESTIMATED'}}
Updated at
2023-08-28

1 organization

1 product

4 indications